The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...